Hydromorphone is five times more potent than morphine, yet shares its chemical structure.

Health · Published 30 September 2026 · Updated 24 October 2026 Swipe more like this →

In short: Derived from morphine and patented in 1923, hydromorphone is a semi-synthetic opioid used for moderate to severe pain. While it offers faster central nervous system penetration due to higher lipid solubility, its potency and potential for respiratory depression make it a high-stakes medication requiring careful clinical management.

Hydromorphone, also known as dihydromorphinone, is a structural isomer of morphine with an identical molecular weight of 285.343. Its chemical modification results in greater lipid solubility, allowing it to cross the blood-brain barrier more efficiently. Clinically, this translates to a potency approximately five times that of morphine, though conversion ratios can range from four to eight times. Unlike many other opioids, it is not metabolized via CYP450 enzymes, instead undergoing extensive liver metabolism into hydromorphone-3-glucuronide, a metabolite that lacks analgesic effects but can cause neurotoxic symptoms like myoclonus in patients with kidney dysfunction.

The drug's onset of action is rapid, typically beginning within 30 minutes for oral doses and under five minutes for intravenous administration. However, its therapeutic window is narrow. Common side effects include sedation, nausea, and constipation, while serious risks involve respiratory depression, circulatory collapse, and potential for abuse. Because of its potency, accidental confusion with morphine—often due to similar naming—has historically led to fatal errors, prompting calls for distinct packaging. In overdose scenarios, the opioid antagonist naloxone is used to reverse its effects, alongside supportive care like assisted ventilation.

Beyond standard analgesia, hydromorphone is subject to strict international control, listed under Schedule II of the United States Controlled Substances Act and similar restricted schedules globally. Its usage has seen significant growth; in the United States, annual production quotas rose from 766 kilograms in 1998 to 5,968 kilograms by 2013. While it remains a staple for cancer-related pain and is increasingly explored for pediatric settings, the evidence base for its comparative effectiveness remains limited, necessitating cautious application and tailored dosing strategies to avoid the risks of addiction, withdrawal, or lethal respiratory depression.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The chemical paradox of a drug that mimics morphine but destroys flesh
• Heroin is a potent morphine derivative that fundamentally alters the brain's reward pathways.
• Are opiates truly the gold standard for pain relief, or just a dangerous myth?
• A young German pharmacist pulled the first drug molecule out of a plant
• The high-potency opioid that demands a precise pharmacological balance
• Hygiene is disease prevention, not merely a shine of cleanliness
• Why the most effective doctors are those who act like students of their patients
• Why measuring the invisible water in our air is a metrological nightmare
• Lungs, folds, and lips turn breath into every human voice
• Why do everyday sounds like jingling coins or chewing sometimes feel physically painful?
• Twenty milk teeth give way to a permanent set of thirty-two
• Half of people with high blood pressure do not know it

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics